The Stereotactic Radiosurgery-Brain Prognostic Index (SRS-BPI): A novel prognostic index for lung cancer patients with brain metastases eligible for SRS

被引：0
|
作者：
Koulouris, A. V. [1 ]
Skribek, M. C. [1 ]
Kamali, C. [1 ]
Grundberg, O. [1 ]
Lampa, E. [2 ]
Gubanski, M. [3 ]
Hydbring, P. [4 ]
Ekman, S. [1 ]
Tsakonas, G. [1 ]
机构：
[1] Karolinska Univ Hosp, Thorac Oncol Ctr, Stockholm, Sweden
[2] Epistat AB, Epidemiol Stat, Uppsala, Sweden
[3] Karolinska Univ Hosp, Dept Radiotherapy, Stockholm, Sweden
[4] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1416
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1361P
引用
收藏
页码：S858 / S858
页数：1
相关论文
共 50 条
  • [21] Outcome and Prognostic Factors of Stereotactic Radiosurgery (SRS) for Melanoma Brain Metastases (MBM) in Era of Effective Systemic Therapy
    Choong, E. S.
    Lo, S.
    Fogarty, G. B.
    Long, G. V.
    Menzies, A. M.
    Guminski, A.
    Shivalingam, B.
    Hong, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E710 - E711
  • [22] Radionecrosis (RN) in Patients with Brain Metastases Treated with Stereotactic Radiosurgery (SRS) and Immunotherapy
    Foster, L. M.
    Squires, B. S.
    Ye, H.
    Marvin, K.
    Seymour, Z. A.
    Grills, I. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E75 - E76
  • [23] SURVIVAL AND PROGNOSTIC FACTORS IN MELANOMA BRAIN METASTASIS (MBM) TREATED WITH STEREOTACTIC RADIOSURGERY (SRS)
    Fitzpatrick, Amanda
    Bartram, Alex
    Rockall, Louise
    Mitchell, Adam
    Palmer, Kieran
    Crusz, Shanthini
    Plowman, Nick
    Lewis, Rachel
    NEURO-ONCOLOGY, 2022, 24 : 17 - 17
  • [24] Stereotactic radiosurgery (SRS) for brain metastases from lung cancer: an evaluation of outcomes at a UK tertiary centre
    Abdul, Haris Puteri
    Smith, Dan
    Al-Salihi, Omar
    Blythe, Kirsty
    Brazil, Lucy
    Chia, Kazumi
    Hassan, Sheila
    Mazumder, Asif
    Skwarski, Michael
    Swampillai, Angela
    LUNG CANCER, 2022, 165 : S58 - S59
  • [25] Which Prognostic Index Is Most Appropriate in the Setting of Delayed Stereotactic Radiosurgery for Brain Metastases?
    Malouff, Timothy
    Bennion, Nathan R.
    Verma, Vivek
    Martinez, Gabriel A.
    Balkman, Nathan
    Bhirud, Abhijeet
    Smith, Tanner
    Lin, Chi
    FRONTIERS IN ONCOLOGY, 2016, 6
  • [26] SRS alone of brain metastases with unfavorable prognostic factors
    Harat, M.
    Blok, M.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S464 - S465
  • [27] Radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT) in the treatment of brain metastases
    Beltramo, G.
    Mantovani, C.
    Zeme, S.
    Soffietti, R.
    Ricardi, U.
    ANNALS OF ONCOLOGY, 2006, 17 : XI61 - XI62
  • [28] Immune checkpoint inhibitors and stereotactic radiosurgery (SRS) in melanoma brain metastases
    Fenioux, Charlotte
    Troussier, Idriss
    Mazeron, Jean-Jacques
    Canova, Charles Henry
    Saiag, Philippe
    Fort, Magali
    Spano, Jean-Philippe
    Kourilsky, Antoine
    Lamproglou, Ioannis
    Maingon, Philippe
    Valery, Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [29] Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)
    Nikitas, John
    Roach, Michael
    Robinson, Cliff
    Bradley, Jeffrey
    Huang, Jiayi
    Perkins, Stephanie
    Tsien, Christina
    Abraham, Christopher
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2020, 21 : 32 - 35
  • [30] EVALUATION OF SURVIVAL FOLLOWING STEREOTACTIC RADIOSURGERY (SRS) FOR MELANOMA BRAIN METASTASES
    Kim, Esther
    Kailas, Shilpa
    Sarparast, Aryan
    Keller, Andrew
    Bhattal, Gurjaspreet
    Dajac, Joshua
    Do, Tiffanie
    Ismail, Rahim
    Buntinx-Krieg, Talayesa
    Pavlovic, Zoran
    Babb, Jacqueline
    Ramakrishna, Naren
    NEURO-ONCOLOGY, 2016, 18 : 26 - 27
12345